These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 7722309)

  • 1. Peptides control the gain and loss of allele specificity by mutated MHC class I molecules.
    Hengel H; Burke K; Kyburz D; Zinkernagel RM; Koszinowski UH
    J Immunol; 1995 May; 154(9):4557-64. PubMed ID: 7722309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.
    Alexander-Miller MA; Burke K; Koszinowski UH; Hansen TH; Connolly JM
    J Immunol; 1993 Jul; 151(1):1-10. PubMed ID: 8392095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTL escape viral variants. I. Generation and molecular characterization.
    Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
    Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
    Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single amino acid substitution in an MHC class I molecule allows heteroclitic recognition by lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes.
    Muller D; Pederson K; Murray R; Frelinger JA
    J Immunol; 1991 Aug; 147(4):1392-7. PubMed ID: 1907995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
    Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
    J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of peptides lacking consensus anchor residue alters H-2Ld serologic recognition.
    Solheim JC; Carreno BM; Smith JD; Gorka J; Myers NB; Wen Z; Martinko JM; Lee DR; Hansen TH
    J Immunol; 1993 Nov; 151(10):5387-97. PubMed ID: 7693810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Q7 alpha 3 domain alters T cell recognition of class I antigens.
    Aldrich CJ; Lowen LC; Mann D; Nishimura M; Hood L; Stroynowski I; Forman J
    J Immunol; 1991 May; 146(9):3082-90. PubMed ID: 1849941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection.
    Speiser DE; Kyburz D; Stübi U; Hengartner H; Zinkernagel RM
    J Immunol; 1992 Aug; 149(3):972-80. PubMed ID: 1634779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
    Hornell TM; Solheim JC; Myers NB; Gillanders WE; Balendiran GK; Hansen TH; Connolly JM
    J Immunol; 1999 Sep; 163(6):3217-25. PubMed ID: 10477590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of peptide-specific CD8+ CTL clones in beta 2-microglobulin-deficient mice.
    Cook JR; Solheim JC; Connolly JM; Hansen TH
    J Immunol; 1995 Jan; 154(1):47-57. PubMed ID: 7995959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential usage of V alpha 4 and V beta 10 T cell receptor genes by lymphocytic choriomeningitis virus glycoprotein-specific H-2Db-restricted cytotoxic T cells.
    Aebischer T; Oehen S; Hengartner H
    Eur J Immunol; 1990 Mar; 20(3):523-31. PubMed ID: 2138558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice.
    Moskophidis D; Lechner F; Hengartner H; Zinkernagel RM
    J Immunol; 1994 May; 152(10):4976-83. PubMed ID: 8176216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
    van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
    J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide.
    Schulz M; Aichele P; Schneider R; Hansen TH; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1991 May; 21(5):1181-5. PubMed ID: 1709866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.